We design specific enzymatic keys to unlock bacterial biofilms. We don't kill the bacteria; we remove their defense, restoring microbiome balance.
Bacteria protect themselves with a structural layer called Extracellular Polysaccharides (EPS). This biofilm acts as a shield, allowing bacteria to evade immune systems, resist chemicals, and thrive where they shouldn't.
Current solutions are blunt instruments—harsh chemicals or antibiotics that destroy everything, including beneficial microbes.
We use an AI-driven pipeline to identify and design depolymerase enzymes. These enzymes act as molecular scissors, cutting the specific chemical bonds of the biofilm matrix.
Biofilms are the natural home for both healthy and harmful bacteria. Indiscriminate removal disrupts this ecosystem, leading to dysbiosis. We offer a targeted approach that selectively dismantles pathogenic defenses while preserving the healthy biofilm structure essential for skin balance.
By stripping this defense, the pathogen loses its fitness. It is then outcompeted by beneficial bacteria or naturally cleared through detachment.
Cutibacterium acnes forms a resilient biofilm that drives inflammation. Our enzymes degrade this layer, reducing inflammatory potential without disturbing commensal bacteria.
Staphylococcus aureus overgrowth is protected by a robust biofilm. Removing this layer allows the skin microbiome to recover, reducing flare-up severity.
Precision modulation enables new claims around skin balance, clarity, and resilience. A truly microbiome-preserving active ingredient.
Our platform solves biofilm challenges in environments where traditional cleaning fails.
For food-tech and consumer goods requiring non-toxic, biocompatible solutions where harsh chemicals are prohibited.
Microbiome-sensitive environments where broad-spectrum eradication is detrimental. We target the pathogen, not the ecosystem.
Complex micro-structures (medical devices, membranes, sensors...) where mechanical scrubbing is impossible. Our enzymes penetrate where liquids flow.
Potentiate your existing actives. Break the biofilm diffusion barrier to restore the efficacy of standard preservatives or antifungals.
A proprietary computational engine that generates candidate depolymerases for bacterial capsule types with high hit rates.
We are not a drug company; we are an enzyme discovery engine. You provide the strain; we deliver the enzyme sequence.
Built on a strong track record of academic excellence, rigorously optimized for efficient catalytic activity.